Flagship Harbor Advisors’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
Flagship Harbor Advisors's HCAT Position: Q3 2020 in Review
Flagship Harbor Advisors sold out of Health Catalyst (HCAT) in Q3 2020, closing a stake of 136 shares — an estimated $3K sold.
Flagship Harbor Advisors first reported a position in HCAT in Q2 2020 and held it in 1 quarter. The position peaked at $3K in Q2 2020. 138 funds tracked by Wall St. Rank hold HCAT as of Q3 2020.
- Flagship Harbor Advisors reported no remaining Health Catalyst position as of Q3 2020 after selling out during the quarter.
- Flagship Harbor Advisors sold 136 Health Catalyst shares in Q3 2020, an estimated $3K.
- Flagship Harbor Advisors first reported a position in Health Catalyst in Q2 2020 and held it in 1 quarter.
- Flagship Harbor Advisors's Health Catalyst position peaked at $3K in Q2 2020.
- 138 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2020.
Based on Flagship Harbor Advisors's 13F filing for Q3 2020, filed 13 Oct 2020.